Email this article Clinical, diagnostic and prognostic value of cytogenetic and immunological impairments at chronic lymphoblastic
- Authors: Rogova ES1, Rogova EC1
-
Affiliations:
- Issue: Vol 13, No 1-2 (2013)
- Pages: 68-70
- Section: Articles
- URL: https://aspvestnik.ru/2410-3764/article/view/24727
- DOI: https://doi.org/10.17816/2072-2354.2013.0.1-2.68-70
- ID: 24727
Cite item
Full Text
Abstract
Chronic lymphatic leukemia (CLL), the most common type of leukemia so the clinical picture and especially its course have been well investigated. At the same time, the lack of the necessary methodological approaches within long years didn't allow to make attempt to decipher the biological nature of the disease. The emergence of the modern cytogenetic, immunological and molecular methods has caused an explosion of interest in the study of CLL, and now the greatest amount of research in the field of Hematology is dedicated to the disease.
Keywords
Full Text
Клиникодиагностическое и прогностическое значение иммунологических и цитогенетических нарушений при хроническом лимфолейкозе×
References
- Воробьев А.И. Руководство по гематологии. Ньюдиамед, 2005
- F. Caligaris-Cappioetal. Towards a better understanding of the biology of B-chronic lymphocytic leukemia. Sixth Meeting of the European Hematology Association, Frankfurt, Germany, 21-24 June 2001, Educational book, pp. 102-106.
- P. Youinou et al. CD5 expression inhuman B-cellpopulation. Immunol Today. 1999,20, 312-316.
- T.J. Hamblin et al. Unmutated IgV(H) genes are associated with more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94, 1848-1854
- R.N. Damle et al. IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94, 1840-1847.
- V Российская онкологическая конференция «Биологические особенности хронического лимфолейкоза и современные подходы к его терапии» М.А. Волкова, 2001.
- H. Dohner et al. Risk classification of chronic lymphocytic leukemia based on genetics. Sixth Meeting of the European Hematology Association, Frankfurt, Germany, 21-24 June 2001, Educational book, pp. 107-109.
- H. Dohner et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997, 89, 2516-2522.
- El-Deiry WS, TokinoT, Velculescu VE, et al. WAF1.аpotential mediator of p53 tumour suppression. Cell 1993; 75
- Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene.
- Carbone R, Pearson M, Minucci S, Pelicci RG. PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene 2002; 21: 1633-40.
- Dohner H, Stilgenbauer S, James MR, etal. 11q deletions identify new subsetof B-cell chronic lymphocytic leukemia characterized by extensive nodal in volvement and inferior prognosis. Blood 1997; 89: 2516–22
- Prives C. Signaling to p53: breaing the MDM2-p533 circuit. Cell 1998; 98:5–8.
- A. Roeberetal. P53 aberrations in B-CLL predict survival and are associated with in vivo resistance to therapy. Blood 2000, 96, 175b, abstr. 4463.
Supplementary files
